With these funds the Institute for Drug Resistance (IDR) was created to serve the drug resistance research and clinical communities. Founded upon the observation that close parallels can be drawn between resistance seen in one disease state and resistance within another, the IDR believes that cross-disciplinary collaboration and discussion could allow for a better understanding of resistance and result in real clinical benefits.
Our goal is to shift the paradigm of drug resistance first in drug design strategies and realizing the parallels of quickly evolving diseases. We plan to achieve this through interdisciplinary communication and synergistic collaboration. The institute will: Facilitate connection of existing expertise, provide infrastructure for targeting quickly evolving diseases, and enable collaborations between research and industrial scientists and clinicians.